Andere talen Ibnsina Pharma

Aandelen

ISPH

EGS512O1C012

slotkoers Egyptian Exchange Andere beurzen 00:00:00 19-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,47 ^EGP	+4,22%		+10,76%	-21,34%

03/03	Ibnsina Pharma rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Ibnsina Pharma rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	03/03
Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index	05/02
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13-08-23
Ibnsina Pharma(CASE:ISPH) dropped from EGX 30 Index	02-08-23
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-23
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2022	01-03-23
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15-11-22
Ibnsina Pharma(CASE:ISPH) dropped from S&P Global BMI Index	19-09-22
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	14-08-22
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-22
Ibn Sina Pharma Company (S.A.E) acquired El Shorouk Hospital for EGP 430 million.	22-05-22
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2021	23-03-22
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	14-11-21
Ibn Sina Pharma Company (S.A.E.) Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021	16-08-21
Ibnsina Pharma Reports Consolidated and Standalone Earnings Results for the First Quarter of 2021	01-06-21
Ibnsina Pharma Announces Board Changes	04-04-21
Ibnsina Pharma Appoints Mohamed Mohsen Mohamed Mahgoub as CEO	04-04-21
Ibnsina Pharma Reports Earnings Results for the Full Year 2020	04-04-21
Ibn Sina Pharma (S.A.E) Announces Audited Standalone Earnings Results for the Full Year Ended December 31, 2020	01-03-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ibnsina Pharma

Aandelen

ISPH

EGS512O1C012

Andere talen

Filters